Get the Stockscreener App
0.1468
275.45%
0.1077
Amplia Therapeutics Limited Stock (INNMF) Forecast
The Amplia Therapeutics Limited (INNMF) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.0112, representing a -92.38% decrease from the current price of $0.1468. The highest analyst price target is $0.018, and the lowest is $0.00435.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INNMF Price Target
Average 0.0187
(-87.25% Downside)
Long-term INNMF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Amplia Therapeutics Limited financial reports and earnings history, Amplia Therapeutics Limited (INNMF) stock could reach $0.099 by 2030, $0.3313 by 2040 and $0.573 by 2050. See the projected annual prices until 2050 of the Amplia Therapeutics Limited stock below:
- Amplia Therapeutics Limited (INNMF) is expected to reach an average price of $0.2144 in 2035, with a high prediction of $0.2202 and a low estimate of $0.2042. This indicates an $46.07% rise from the last recorded price of $0.1468.
- Amplia Therapeutics Limited (INNMF) stock is projected to chart a bullish course in 2040, with an average price target of $0.3313, representing an $125.66% surge from its current level. The forecast ranges from a conservative $0.29 to a sky-high $0.3313.
- Our analysts predict Amplia Therapeutics Limited (INNMF) to jump 182.91% by 2045, soaring from $0.4336 to an average price of $0.4153, potentially reaching $0.4442. While $0.4336 is the low estimate, the potential upside is significant.
- Amplia Therapeutics Limited (INNMF) stock is expected to climb by 2050, reaching an average of $0.5801, a $295.16% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.573 and $0.524, respectively, highlighting the market's uncertainty.
Amplia Therapeutics Limited Stock (INNMF) Year by Year Forecast
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2025
Amplia Therapeutics Limited Stock (INNMF) is expected to reach an average price of $0.0185 in 2025, with a high prediction of $0.0366 and a low estimate of $0.000454. This indicates an -87.39% fall from the last recorded price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $0.0068 | $0.00435 | $0.018 | -95.37% |
| September, 2025 | $0.00369 | $0.0029 | $0.0103 | -97.48% |
| October, 2025 | $0.00113 | $0.00201 | $0.0247 | -99.23% |
| November, 2025 | $0.0169 | $0.0101 | $0.0238 | -88.46% |
| December, 2025 | $0.00212 | $0.00208 | $0.006 | -98.55% |
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2026
The predicted value for Amplia Therapeutics Limited (INNMF) in 2026 is set at an average of $0.024. Estimates vary from a peak of $0.047 to a trough of $0.000943, indicating an -83.67% surge from the present price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0188 | $0.00238 | $0.0188 | -87.22% |
| February, 2026 | $0.0291 | $0.0079 | $0.0296 | -80.20% |
| March, 2026 | $0.00408 | $0.00408 | $0.0123 | -97.22% |
| April, 2026 | $0.0153 | $0.00824 | $0.0153 | -89.60% |
| May, 2026 | $0.0354 | $0.0128 | $0.0354 | -75.88% |
| June, 2026 | $0.0157 | $0.0157 | $0.0348 | -89.28% |
| July, 2026 | $0.00061 | $0.0102 | $0.0144 | -99.58% |
| August, 2026 | $0.0323 | $0.00688 | $0.0213 | -77.96% |
| September, 2026 | $0.0203 | $0.0272 | $0.0412 | -86.19% |
| October, 2026 | $0.0206 | $0.0164 | $0.0219 | -85.97% |
| November, 2026 | $0.0247 | $0.000943 | $0.0272 | -83.18% |
| December, 2026 | $0.0383 | $0.0329 | $0.047 | -73.91% |
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Amplia Therapeutics Limited (INNMF) is $0.0347, with a high forecast of $0.0644 and a low forecast of $0.00499. This indicates an -76.36% decrease from the last price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0266 | $0.0226 | $0.0281 | -81.88% |
| February, 2027 | $0.00499 | $0.00499 | $0.0332 | -96.60% |
| March, 2027 | $0.0421 | $0.0315 | $0.0528 | -71.29% |
| April, 2027 | $0.0287 | $0.0287 | $0.0375 | -80.42% |
| May, 2027 | $0.0392 | $0.0327 | $0.0392 | -73.30% |
| June, 2027 | $0.0578 | $0.0109 | $0.0586 | -60.59% |
| July, 2027 | $0.0406 | $0.0406 | $0.0438 | -72.37% |
| August, 2027 | $0.0452 | $0.0349 | $0.0452 | -69.22% |
| September, 2027 | $0.0644 | $0.0169 | $0.0644 | -56.12% |
| October, 2027 | $0.0453 | $0.05 | $0.0636 | -69.15% |
| November, 2027 | $0.0295 | $0.0411 | $0.0468 | -79.88% |
| December, 2027 | $0.0616 | $0.0228 | $0.0512 | -58.05% |
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2028
In 2028, Amplia Therapeutics Limited (INNMF) is projected to reach an average price of $0.0582, with a high projection of $0.0876 and a low estimate of $0.0287. This indicates an -60.37% fall from the last price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0635 | $0.0557 | $0.0702 | -56.74% |
| February, 2028 | $0.051 | $0.0472 | $0.053 | -65.28% |
| March, 2028 | $0.0542 | $0.0287 | $0.0571 | -63.11% |
| April, 2028 | $0.0687 | $0.0615 | $0.076 | -53.18% |
| May, 2028 | $0.0572 | $0.0534 | $0.0627 | -61.04% |
| June, 2028 | $0.0347 | $0.0347 | $0.0631 | -76.38% |
| July, 2028 | $0.0809 | $0.0609 | $0.0818 | -44.91% |
| August, 2028 | $0.0596 | $0.0596 | $0.069 | -59.43% |
| September, 2028 | $0.0691 | $0.0631 | $0.0691 | -52.92% |
| October, 2028 | $0.0866 | $0.0406 | $0.0876 | -40.99% |
| November, 2028 | $0.0716 | $0.0716 | $0.0753 | -51.22% |
| December, 2028 | $0.0536 | $0.0657 | $0.0694 | -63.46% |
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2029
The 2029 price forecast for Amplia Therapeutics Limited Stock (INNMF) is $0.0787 on average, with a high prediction of $0.1108 and a low estimate of $0.0466. This represents an -46.40% decrease from the previous price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0934 | $0.0466 | $0.0934 | -36.36% |
| February, 2029 | $0.0766 | $0.0786 | $0.0924 | -47.84% |
| March, 2029 | $0.0753 | $0.0719 | $0.0778 | -48.74% |
| April, 2029 | $0.0777 | $0.0525 | $0.0811 | -47.06% |
| May, 2029 | $0.095 | $0.0843 | $0.0992 | -35.29% |
| June, 2029 | $0.0817 | $0.078 | $0.084 | -44.37% |
| July, 2029 | $0.0836 | $0.0584 | $0.0871 | -43.04% |
| August, 2029 | $0.0975 | $0.09 | $0.105 | -33.57% |
| September, 2029 | $0.0842 | $0.0842 | $0.0942 | -42.63% |
| October, 2029 | $0.0644 | $0.0644 | $0.093 | -56.15% |
| November, 2029 | $0.1096 | $0.0904 | $0.1108 | -25.31% |
| December, 2029 | $0.0965 | $0.0957 | $0.1005 | -34.30% |
Amplia Therapeutics Limited Stock (INNMF) Price Forecast for 2030
Amplia Therapeutics Limited Stock (INNMF) is expected to reach an average price of $0.1022 in 2030, with a high forecast of $0.134 and a low forecast of $0.0703. This signifies an -30.40% decrease from the last price of $0.1468.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.099 | $0.0904 | $0.099 | -32.54% |
| February, 2030 | $0.1166 | $0.0703 | $0.1166 | -20.55% |
| March, 2030 | $0.1016 | $0.1014 | $0.1154 | -30.80% |
| April, 2030 | $0.0838 | $0.0965 | $0.1027 | -42.93% |
| May, 2030 | $0.1142 | $0.0762 | $0.105 | -22.21% |
| June, 2030 | $0.1202 | $0.1071 | $0.1224 | -18.12% |
| July, 2030 | $0.1056 | $0.1027 | $0.1089 | -28.05% |
| August, 2030 | $0.1072 | $0.0822 | $0.111 | -26.99% |
| September, 2030 | $0.1205 | $0.1128 | $0.1282 | -17.89% |
| October, 2030 | $0.1123 | $0.1089 | $0.1194 | -23.53% |
| November, 2030 | $0.0881 | $0.0881 | $0.117 | -39.98% |
| December, 2030 | $0.124 | $0.114 | $0.134 | -15.54% |
5.71%
0.34%
Cap:
|
Volume (24h):